XSpray Pharma AB Strategic Asset Allocation Index
XSpray Pharma AB strategic asset allocation index. XSpray Pharma AB (XSPRAY) has a Strategic Asset Allocation Index of 11.7% as of December 2025. Strategic assets (PP&E of Skr70.99 Million plus long-term investments of Skr-) total Skr70.99 Million, measured against net assets of Skr604.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See XSPRAY net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of XSpray Pharma AB (2016–2025)
Strategic asset allocation index of XSpray Pharma AB from 2016 to 2025. This chart shows how XSpray Pharma AB's Strategic Asset Allocation Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 11.7%, representing strategic assets of Skr70.99 Million against net assets of Skr604.65 Million SEK. Check XSpray Pharma AB (XSPRAY) tangible net worth to evaluate the tangible quality of the company's equity base.
XSpray Pharma AB Strategic Asset Allocation Index by Year (2016–2025)
XSpray Pharma AB strategic asset allocation index by year from 2016 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for XSpray Pharma AB from 2016 to 2025, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XSpray Pharma AB (XSPRAY) market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.7% | Skr70.99 Million | Skr70.99 Million | Skr- | Skr604.65 Million | ▼ -1.0 pp |
| 2024 | 12.7% | Skr79.19 Million | Skr79.19 Million | Skr- | Skr623.10 Million | ▼ -2.8 pp |
| 2023 | 15.5% | Skr107.65 Million | Skr107.65 Million | Skr- | Skr693.41 Million | ▲ +3.9 pp |
| 2022 | 11.6% | Skr64.60 Million | Skr64.60 Million | Skr- | Skr556.02 Million | ▲ +4.1 pp |
| 2021 | 7.5% | Skr44.60 Million | Skr44.60 Million | Skr- | Skr591.75 Million | ▲ +0.2 pp |
| 2020 | 7.3% | Skr42.67 Million | Skr42.67 Million | Skr- | Skr582.59 Million | ▼ -4.2 pp |
| 2019 | 11.5% | Skr43.03 Million | Skr43.03 Million | Skr- | Skr373.71 Million | ▲ +7.0 pp |
| 2018 | 4.6% | Skr13.73 Million | Skr13.73 Million | Skr- | Skr301.72 Million | ▲ +3.0 pp |
| 2017 | 1.6% | Skr2.46 Million | Skr2.46 Million | Skr- | Skr155.66 Million | ▲ +0.5 pp |
| 2016 | 1.0% | Skr480.00K | Skr480.00K | Skr- | Skr46.47 Million | — |